Apnimed, Inc.

Other Cambridge, MA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Other
Headquarters
Cambridge, MA
Street
39 John F. Kennedy Street, 4th Flr.
Zip
02138

Offering

Total offering
$25M
Amount sold
$25M
First sale
Mar 11, 2026
Min investment
$0
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
2

How this filing compares

Ranked #47 of 222 Other filings in March 2026 by offering amount.

Median Other filing in March 2026: $5.4M. This offering is 4.6× the median.

Other Massachusetts filings this week: BCV Emerge Fund V, L.P., LONG POINT INVESTORS, L.P., Neosoma, Inc., TA Realty Digital Real Estate Fund I, L.P., TA Realty Residential Real Estate Fund (DC), L.P.

Leadership

Lawrence G. Miller — Executive Officer (also: Director)

Barry Wohl — Executive Officer

Dennis Molnar — Executive Officer

Joseph C. Avellone — Director

Francois Beaubien — Director

Isaac Cheng — Director

Chris C. Dimitropoulos — Director

Paul Fonteyne — Director

Kevin C. Lind — Director

Gary Sender — Director

Ramzi Benamar — Executive Officer

Filing details

Apnimed, Inc. filed a Form D with the SEC on March 27, 2026.

Other newest Other companies

Other newest companies in Massachusetts